-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Shanghai Pharmaceutical (02607.HK) issued an announcement. In order to rationally allocate R&D resources and focus on advantageous R&D projects, the company decided to terminate clinical trials and subsequent development of injectable salvianolic acid A based on a comprehensive evaluation of factors such as future market value, business collaboration, and subsequent development investment in R&D projects.

Zhitongcaijing·07/24/2026 11:49:03
Listen to the news
Zhitong Finance App News, Shanghai Pharmaceutical (02607.HK) issued an announcement. In order to rationally allocate R&D resources and focus on advantageous R&D projects, the company decided to terminate clinical trials and subsequent development of injectable salvianolic acid A based on a comprehensive evaluation of factors such as future market value, business collaboration, and subsequent development investment in R&D projects.